Skip to main content

Ben Ho Park Archives

Vanderbilt-Ingram Cancer Center earns NCI Merit Award

Oct. 17, 2023—Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.

Read more


Foundation funds research to block drug resistance in cancer treatment

Sep. 1, 2023—The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.

Read more


Liquid biopsy test may detect early-stage and low DNA-shedding cancers

May. 31, 2023—Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.

Read more


Cell-free breast cancer “biopsy”

Aug. 11, 2022—The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer.

Read more


Couple’s gift helps support immunotherapy research

Aug. 11, 2022—Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies.

Read more


Conquer Cancer awards given to five hematology-oncology fellows

May. 26, 2022—Five Vanderbilt University Medical Center hematology and oncology fellows will receive awards from Conquer Cancer, the ASCO Foundation, during the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, June 3-7.

Read more


Park named director of Vanderbilt-Ingram Cancer Center

Feb. 17, 2022—Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director.

Read more


Park named to new role as deputy director of Vanderbilt-Ingram Cancer Center

Aug. 19, 2021—Ben Ho Park, MD, PhD, Cornelius Abernathy Professor of Medicine, has been named deputy director of Vanderbilt-Ingram Cancer Center (VICC).

Read more


Susan G. Komen funds VICC breast cancer initiatives

Jul. 15, 2021—Susan G. Komen has announced breast cancer research grants totaling $14 million, including funding for three separate initiatives led by Vanderbilt-Ingram Cancer Center (VICC) researchers.

Read more


AACR second session to feature Vanderbilt researchers

May. 12, 2021—The second session of the American Association for Cancer Research (AACR) Annual meeting, May 17-21, features several researchers from Vanderbilt-Ingram Cancer Center.

Read more


Park named director of Hematology and Oncology at VICC

Oct. 21, 2020—After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology.

Read more


Park named interim Hematology and Oncology director

Jan. 9, 2020—Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more